Abstract |
The main aim of the present study was to investigate the association between several genetic polymorphisms (in glutathione S-transferase members and DNA repair genes) and clinical response to chemotherapy in locally advanced breast cancer. A sequential series of 101 patients were prospectively included in this study. Clinical assessment of treatment was accomplished by comparing initial tumor size with preoperative tumor size using revised RECIST guideline (version 1.1). Clinical response was regarded as a response or no response. There was no difference between non-responders and responders for the prevalence of genotypes of the study polymorphisms.
|
Authors | Mostafa Saadat, Maryam Khalili, Meysam Nasiri, Mehrdad Rajaei, Shahpour Omidvari, Iraj Saadat |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 419
Issue 1
Pg. 117-9
(Mar 02 2012)
ISSN: 1090-2104 [Electronic] United States |
PMID | 22330804
(Publication Type: Journal Article)
|
Copyright | Copyright © 2012 Elsevier Inc. All rights reserved. |
Chemical References |
- Antigens, Nuclear
- DNA-Binding Proteins
- Nuclear Proteins
- X-ray Repair Cross Complementing Protein 1
- GSTZ1 protein, human
- glutathione S-transferase T1
- GSTO1 protein, human
- Glutathione Transferase
- glutathione S-transferase M1
- DNA-Activated Protein Kinase
- PRKDC protein, human
- Xrcc6 protein, human
- Ku Autoantigen
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antigens, Nuclear
(genetics)
- Antineoplastic Protocols
- Breast Neoplasms
(drug therapy)
- DNA Repair
(genetics)
- DNA-Activated Protein Kinase
(genetics)
- DNA-Binding Proteins
(genetics)
- Drug Resistance
(genetics)
- Female
- Glutathione Transferase
(genetics)
- Humans
- Inactivation, Metabolic
(genetics)
- Ku Autoantigen
- Middle Aged
- Nuclear Proteins
(genetics)
- Polymorphism, Genetic
- Prospective Studies
- Treatment Outcome
- X-ray Repair Cross Complementing Protein 1
|